ImmunityBio shares target raised by Piper Sandler on potential approval By Investing.com
© Reuters. On Monday, Piper Sandler adjusted its price target for ImmunityBio Inc (NASDAQ:IBRX), increasing it to $5.00 from the ...
© Reuters. On Monday, Piper Sandler adjusted its price target for ImmunityBio Inc (NASDAQ:IBRX), increasing it to $5.00 from the ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.